Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies
ABSTRACT The enzyme glutamic acid decarboxylase (GAD), present in GABAergic neurons and in pancreatic beta cells, catalyzes the conversion of gamma-aminobutyric acid (GABA). The cerebellum is highly susceptible to immune-mediated mechanisms, with the potentially treatable autoimmune cerebellar ataxi...
Main Authors: | Tiago Silva Aguiar, Andrea Fragoso, Carolina Rouanet de Albuquerque, Patrícia de Fátima Teixeira, Marcus Vinícius Leitão de Souza, Lenita Zajdenverg, Soniza Vieira Alves-Leon, Melanie Rodacki, Marco Antônio Sales Dantas de Lima |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000300142&lng=en&tlng=en |
Similar Items
-
Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
by: Marios Hadjivassiliou, et al.
Published: (2022-08-01) -
Stiff-Eye Syndrome—Anti-GAD Ataxia Presenting with Isolated Ophthalmoplegia: A Case Report
by: Abel Dantas Belém, et al.
Published: (2021-07-01) -
GAD Antibody-Associated Late-Onset Cerebellar Ataxia in Two Female Siblings
by: Joseph Kuchling, et al.
Published: (2014-11-01) -
An update on Spino-cerebellar ataxias
by: Banashree Mondal, et al.
Published: (2013-01-01) -
Treatable cerebellar ataxias
by: Divya K.P., et al.
Published: (2020-01-01)